TBC1D32
Protein broad-minded
Also known as: bA57L9.1, BROMI, BROMI_HUMAN, C6orf170, C6orf171, dJ310J6.1, FLJ30899, FLJ34235
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q96NH3
- Gene
- TBC1D32
- Ensembl
- ENSG00000146350
- Chromosome
- 6
- Canonical length
- 1257 aa
- Protein class
- Predicted intracellular proteins, Predicted membrane proteins
- Subcellular location
- Mitochondria
OverviewNCBI Gene
This gene encodes a TBC-domain containing protein. Studies of a similar protein in mouse and zebrafish suggest that the encoded protein is involved in sonic hedgehog signaling, and that it interacts with and stabilizes cell cycle-related kinase. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2014]
Canonical amino-acid sequenceUniProt
1257 residues, UniProt reviewed canonical sequence.
>Q96NH3|TBC1D32
1 MAHFSSEDQA MLQAMLRRLF QSVKEKITGA PSLECAEEIL LHLEETDENF HNYEFVKYLR
61 QHIGNTLGSM IEEEMEKCTS DRNQGEECGY DTVVQQVTKR TQESKEYKEM MHYLKNIMIA
121 VVESMINKFE EDETRNQERQ KKIQKEKSHS YRTDNCSDSD SSLNQSYKFC QGKLQLILDQ
181 LDPGQPKEVR YEALQTLCSA PPSDVLNCEN WTTLCEKLTV SLSDPDPVFS DRILKFCAQT
241 FLLSPLHMTK EIYTSLAKYL ESYFLSRENH IPTLSAGVDI TNPNMTRLLK KVRLLNEYQK
301 EAPSFWIRHP EKYMEEIVES TLSLLTVKHN QSHVVSQKIL DPIYFFALVD TKAVWFKKWM
361 HAHYSRTTVL RLLETKYKSL VTTAIQQCVQ YFEMCKTRKA DETLGHSKHC RNKQKTFYYL
421 GQELQYIYFI HSLCLLGRLL IYKQGRKLFP IKLKNKKGLV SLIDLLVLFT QLIYYSPSCP
481 KMTSAAHSEN YSPASMVTEV LWILSDQKEC AVECLYNNIV IETLLQPIHN LMKGNEASPN
541 CSETALIHIA GILARIASVE EGLILLLYGA NMNSSEESPT GAHIIAQFSK KLLDEDISIF
601 SGSEMLPVVK GAFISVCRHI YSTCEGLQVL ITYNLHESIA KAWKKTSLLS ERIPTPVEGS
661 DSVSSVSQES QNIMAWEDNL LDDLLHFAAT PKGLLLLQRT GAINECVTFI FNRYAKKLQV
721 SRHKKFGYGV LVTRVASTAA GGIALKKSGF INELITELWS NLEYGRDDVR VTHPRTTPVD
781 PIDRSCQKSF LALVNLLSYP AIYELVRNQD LPNKTEYSLR EVPTCVIDII DRLIILNSEA
841 KIRSLFNYEQ SHIFGLRDFI IDGLSVERNH VLVRINLVGG PLERILPPRL LEKSDNPYPW
901 PMFSSYPLPN CYLSDITRNA GIKQDNDLDK LLLCLKISDK QTEWIENCQR QFCKMMKAKP
961 DIISGEALIE LLEKFVLHLT ESPSECYFPS VEYTATDANV KNESLSSVQQ LGIKMTVRYG
1021 KFLSLLKDGA ENDLTWVLKH CERFLKQQQT SIKSSLLCLQ GNYAGHDWFV SSLFMIMLGD
1081 KEKTFQFLHQ FSRLLTSAFL WLPRLHISSY LPNDTVESGI HPVYFCSTHY IEMLLKAELP
1141 LVFSAFHMSG FAPSQICLQW ITQCFWNYLD WIEICHYIAT CVFLGPDYQV YICIAVFKHL
1201 QQDILQHTQT QDLQVFLKEE ALHGFRVSDY FEYMEILEQN YRTVLLRDMR NIRLQSTLocalizationUniProt · AlphaFold · HPA
Whether an antibody against TBC1D32 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.28
- Highest tissue expression
- 6.9 nTPM
Expression across tissuesHPA
Tissue
- retina: 6.9 nTPM
- testis: 3.4 nTPM
- cerebral cortex: 2.9 nTPM
- placenta: 2.7 nTPM
- adrenal gland: 2.3 nTPM
- thyroid gland: 2.3 nTPM
Single-cell type
- rod photoreceptor cells: 615 nCPM
- somatotrophs: 390 nCPM
- lactotrophs: 356 nCPM
- gonadotrophs: 321 nCPM
- thyrotrophs: 314 nCPM
- adrenal cortex cells: 238 nCPM
Immune cell
- plasmacytoid DC: 8.2 nTPM
- basophil: 6.1 nTPM
- naive B-cell: 4.5 nTPM
- memory B-cell: 2.6 nTPM
- naive CD4 T-cell: 2.6 nTPM
- NK-cell: 2.6 nTPM
Brain region
- white matter: 12 nTPM
- hypothalamus: 11 nTPM
- basal ganglia: 10 nTPM
- midbrain: 9.9 nTPM
- pons: 9.7 nTPM
- cerebral cortex: 9.6 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about TBC1D32.
Disease | AllUniProt
Conditions TBC1D32 is implicated in, by any mechanism.
- Orofaciodigital syndrome 9 (OFD9) MIM:258865
- Retinitis pigmentosa 100 (RP100) MIM:621280
- Alsahan-Harris syndrome (ALHAS) MIM:621307
Disease | GeneticClinVar
19 pathogenic / likely-pathogenic of 359 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Orofaciodigital syndrome IX
- Retinitis pigmentosa 100
- Alsahan-Harris syndrome
- Hypopituitarism
- Inborn genetic diseases
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.9
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.04
- DepMap mean gene effect
- 0.02
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- determination of left/right symmetry
- embryonic digit morphogenesis
- heart development
- kidney development
- lens development in camera-type eye
- non-motile cilium assembly
- protein localization to cilium
- retinal pigment epithelium development
- roof of mouth development
- smoothened signaling pathway involved in dorsal/ventral neural tube patterning
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Rab-GAP-TBC domain superfamily
- PHAF1/Protein broad-minded
- BROMI, middle region
- BROMI, N-terminal domain
- BROMI, C-terminal Rab TBC-like domain
- Broad-minded protein central region
- Broad-minded protein N-terminal domain
- Broad-minded protein Rab TBC domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of TBC1D32 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads TBC1D32 as an antibody target. Whether an autoantibody or antibody against TBC1D32 could matter depends on whether native TBC1D32 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
TBC1D32 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label TBC1D32 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...